Arizona Bioscience Week Connects Community and Celebrates One of the Fastest Growing Life Science and Healthcare Sectors in the United States.Continue reading→

The National Institutes of Health’s National Cancer Institute (NCI) has awarded a grant for up to $3 million to NuvOx Pharma to initiate a Phase II clinical trial for the investigational drug, NVX-108, in the brain cancer, glioblastoma multiforme (GBM).Continue reading→

Advances R&D for promising portfolio of innovative medicinesContinue reading→

The Arizona Bioindustry Association will honor Arizona Governor Douglas A. Ducey as the Arizona Bioscience Leader of the Year at the 2017 AZBio Awards.  Arizona life science and business leaders as well as guests from across the country will be on hand to applaud Governor Ducey for his leadership and support of Arizona’s growing life science industry and his commitment to growing the state’s knowledge economy.Continue reading→

Brain State Technologies®, a leading neurotechnology company, today announced that it recently raised nearly $200,000 via Kickstarter. The proceeds will be used to fund production of the company’s new B2v2® brainwave balancing headband. Over 623 backers pre-ordered the B2v2, exceeding the original Kickstarter goal by nearly 1,000%.Continue reading→

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the United States Patent and Trademark Office has issued two U.S. Patents covering HTG’s technology and applications of its technology. Continue reading→

Alzheimer’s, a mysterious disease of cognitive decline, was first recognized a century ago. The unremitting illness continues to frustrate the best efforts toward treatment or prevention, and a tidal wave of new cases in the coming decades threatens to overwhelm the nation’s health-care system.Continue reading→